Prescription and over-the-counter medication recalls
Drug recalls come from the FDA's drug enforcement reports. They range from a wrong label to a product that could be harmful, and the risk level on each notice is the FDA's own classification. Never stop a prescribed medication on the strength of a recall notice alone — the notice will say whether to return it, and your prescriber or pharmacist decides what replaces it.
4,474 stored notices, reported between Jun 20, 2012 and Sep 9, 2026. Newest first.
Reported Dec 7, 2016
Salsalate Tablets, USP, 500 mg, packaged in a) 500 count bottles (NDC 42937-703-18); b) 100 count bottles (NDC…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Nationwide Laboratories, LLC
3 more products in this recall
FDA (openFDA drug enforcement)
Reported Dec 7, 2016
Travoprost Ophthalmic Solution USP, 0.004%, a) 2.5 mL and b) 5 mL bottles, Rx only, FOR USE IN THE EYES ONLY, Made in…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Par Pharmaceutical, Inc.
FDA (openFDA drug enforcement)
Reported Nov 30, 2016
NIFEdipine Capsules USP, 10 mg, Rx only, 100 count bottle, Manufactured and distributed by: Actavis Elizabeth LLC, 200…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Actavis Elizabeth LLC
FDA (openFDA drug enforcement)
Reported Nov 30, 2016
Desoximetasone Ointment USP, 0.25%, a) 15 g tubes (NDC 61748-206-15 and b) 60 g tubes (NDC 61748-206-60, Marketed by…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Akorn Inc.
FDA (openFDA drug enforcement)
Reported Nov 30, 2016
AHP NIFEdipine Capsules, 10mg USP, 100 count carton (NDC: 68084-022-01); Individual Blister (NDC: 68084-022-11), Rx…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Amerisource Health Services
FDA (openFDA drug enforcement)
Reported Nov 30, 2016
Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., Lake Forest IL…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Hospira Inc.
FDA (openFDA drug enforcement)
Reported Nov 30, 2016
Diltiazem HCl Extended-release Capsules, USP 120 mg, 100-count bottle (NDC 0378-5220-01), 500-count bottle (NDC…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Mylan Pharmaceuticals Inc.
FDA (openFDA drug enforcement)
Reported Nov 30, 2016
LEVOXYL(R) (levothyroxine sodium tablets, USP), 200 mcg, 100 count bottles, Rx only, Manufactured and Distributed by:…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Pfizer Inc.
FDA (openFDA drug enforcement)
Reported Nov 30, 2016
Ceftriaxone for Injection, USP, 1 gram, 10 Single use Vials, Rx only, For IM or I.V. Use, Manufactured by: Sandoz GMbH…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Sandoz Inc.
FDA (openFDA drug enforcement)
Reported Nov 30, 2016
KENALOG (Triamcinolone Acetonide) Spray with Spray Tube Topical Aerosol, USP, (0.147 mg/g), 15 g bottle, Physician…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Sun Pharmaceutical Industries, Inc.
FDA (openFDA drug enforcement)
Reported Nov 30, 2016
Lactulose Solution, USP, 10 g/15 mL, 15 mL unit dose cups (NDC 66689-039-01), packaged in 15 mL x 50 unit dose cups per…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.VistaPharm, Inc.
FDA (openFDA drug enforcement)
Reported Nov 30, 2016
Amoxicillin for Oral suspension, USP 400 mg/5 mL, 100 mL (when reconstituted), Rx only, Manufactured by: Hikma…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.West-Ward Pharmaceuticals Corp.
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Nov 30, 2016
BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg, Rx Only, 500-count bottles, Manufactured by Cadila…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Zydus Pharmaceuticals USA Inc.
FDA (openFDA drug enforcement)
Reported Nov 23, 2016
Bupropion Hydrochloride Extended-Release Tablets, USP (XL), 300 mg, a) 90-count bottle (NDC 68001-264-05), b) 500-count…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Amerisource Health Services
FDA (openFDA drug enforcement)
Reported Nov 23, 2016
FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit , 5 oz., Rx only, Manufactured for CutisPharma…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.CutisPharma, Inc.
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Nov 23, 2016
Zeasorb AF (miconazole nitrate), 2%, cures most athlete's foot, Net wt. 2.5 OZ (71 g), Manufactured for: Steifel…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.GSK Consumer Healthcare
FDA (openFDA drug enforcement)
Reported Nov 23, 2016
L-Cysteine Hydrochloride Injection, USP, 0.5 g/10 mL (50 mg/mL), 10 mL Single Dose Vial (NDC 66758-004-01), packaged in…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Sandoz Inc.
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Nov 16, 2016
Clonazepam Tablets, USP, 0.5 mg, packaged in a)100- count unit dose box of 10 x 10 blister cards (NDC 51079-881-20) and…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Nov 16, 2016
Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter Healthcare…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Sandoz Inc.
FDA (openFDA drug enforcement)
Reported Nov 16, 2016
Kamedis BIO-HERBAL DANDRUFF CARE THERAPEUTIC 2-STEP DANDRUFF CARE SYSTEM - Kamedis Bio-Herbal Dandruff Care 0.1%…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Taro Pharmaceuticals U.S.A., Inc.
FDA (openFDA drug enforcement)
Reported Nov 16, 2016
Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Wells Pharmacy Network, LLC
6 more products in this recall
FDA (openFDA drug enforcement)
Reported Nov 9, 2016
Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia,…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Actavis Laboratories, FL, Inc.
FDA (openFDA drug enforcement)
Reported Nov 9, 2016
Sodium Chloride Ophthalmic Solution, USP, 5%, 15 mL (0.5 fL oz.) bottle, Akorn, Inc., Lake Forest, IL 60045, NDC…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Akorn Inc.
FDA (openFDA drug enforcement)
Reported Nov 9, 2016
Gildess 1.5/30 (norethindrone acetate, 1.5 mg and ethinyl estradiol tablets, 0.03 mg, USP), 21 count, (a) 3 blisters…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Par Pharmaceutical, Inc.
4 more products in this recall
FDA (openFDA drug enforcement)
Free recall alerts
Get alerted about new Medication recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.
Related categories
RecallNow is not a government agency. Every notice above was published by the FDA, USDA FSIS or CPSC and links back to its source. Browse the whole archive.